Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D.

The relationship between the genetic variability in the V3 loop and the biological characteristics of 38 biological clones from 5 European and 7 African HIV-1 isolates belonging to 3 different subtypes (subtype A, B, and D) was investigated. Seventeen of 19 clones displaying a syncytium-inducing (SI) capacity had a positively charged amino acid located at position 11 and/or 25 in the V3 loop sequence. All 19 non-syncytium-inducing (NSI) virus clones lacked such a positive charge at the same positions (p < 0.001). The mean of net charge in the overall V3 loop sequences of the SI clones was higher than that of the NSI clones (p < 0.001). Within the same strains, the SI clones replicated faster/higher than the NSI clones in peripheral blood mononuclear cells (p < 0.01), but not in CD4+ T cell cultures (p > 0.1). All SI clones but only 5 of 19 NSI clones could replicate in human continuous T cell and monocytic cell lines (p < 0.001). A higher number of positively charged amino acid substitutions was found among the subtype D SI clones. Only one of eight autologous sera tested had the ability to neutralize the contemporaneously isolated NSI clones, but not the SI clones. This study indicates that the V3 loop amino acid sequences of HIV-1 biological clones from different origins belonging to different genetic subtypes are clearly correlated with viral syncytium-inducing capacity, cell tropism, and replication rate.

[1]  P. Piot,et al.  Cross‐neutralizing antibodies to HIV‐1ANT70 and HIV‐1 IIIB in sera of African and Belgian HIV‐1 -infected individuals , 1994, AIDS.

[2]  Yves Van de Peer,et al.  Molecular phylogeny of part of the env gene of HIV‐1 strains isolated in Côte d'lvoire , 1994, AIDS.

[3]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[4]  C. Kuiken,et al.  Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Margolin,et al.  V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.

[6]  L. Stamatatos,et al.  Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability , 1993, Journal of virology.

[7]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[8]  H. Schuitemaker,et al.  Relation of phenotype evolution of HIV-1 to envelope V2 configuration. , 1993, Science.

[9]  D. Ho,et al.  Biological cloning of functionally diverse quasispecies of HIV-1. , 1993, AIDS research and human retroviruses.

[10]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[11]  C. Cheng‐Mayer,et al.  Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Schuitemaker,et al.  Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain , 1992, Journal of virology.

[13]  C. Kuiken,et al.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.

[14]  E. Holmes,et al.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[16]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[17]  R A Houghten,et al.  Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. , 1992, Science.

[18]  A. Cann,et al.  The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism , 1992, Journal of virology.

[19]  S. M. Stearns,et al.  Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity , 1992, Journal of virology.

[20]  P. Simmonds,et al.  Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.

[21]  J. Levy,et al.  CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. , 1991, Cellular immunology.

[22]  H. Temin,et al.  Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer , 1991, Journal of virology.

[23]  J. Goudsmit,et al.  Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine development , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Y. Masuho,et al.  Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. , 1991, Virology.

[25]  R. Fouchier,et al.  Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual , 1991, Journal of virology.

[26]  H. Schuitemaker,et al.  Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture , 1991, Journal of virology.

[27]  A. Profy,et al.  Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1 , 1990, Science.

[28]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Douglas,et al.  Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. , 1990, Journal of immunological methods.

[30]  H. Buc,et al.  Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent. , 1990, The EMBO journal.

[31]  M. Baseler,et al.  Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies , 1990, The Journal of experimental medicine.

[32]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.

[33]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[34]  L. Loeb,et al.  Fidelity of HIV-1 reverse transcriptase. , 1988, Science.

[35]  C. Debouck,et al.  Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Huisman,et al.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.

[37]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[38]  R. Schooley,et al.  Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins , 1987, Journal of virology.

[39]  J. Lifson,et al.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.

[40]  M. Gonda,et al.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Reddy,et al.  HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients , 1985, Cell.

[42]  M. Martin,et al.  Molecular organization of the AIDS retrovirus , 1985, Cell.

[43]  I Lefkovits,et al.  Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. , 1984, Immunology today.

[44]  F. Walshe.  The structure of medicine. , 1948, Lancet.

[45]  P. Krijnen,et al.  Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.

[46]  E. Delwart,et al.  A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.